Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000199246 | SCV000252109 | uncertain significance | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | Observed with a second PNPT1 variant on the opposite allele (in trans) in a patient with arm and leg weakness, developmental delay, scoliosis, epilepsy, and sensory axonal polyneuropathy (PMID: 35303589); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35303589) |
Fulgent Genetics, |
RCV000765691 | SCV000897033 | uncertain significance | Combined oxidative phosphorylation defect type 13; Autosomal recessive nonsyndromic hearing loss 70 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000199246 | SCV001084377 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001336837 | SCV001530339 | uncertain significance | Combined oxidative phosphorylation defect type 13 | 2018-03-25 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Prevention |
RCV004541264 | SCV004773193 | likely benign | PNPT1-related disorder | 2020-12-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |